Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001445305-14-000397
Filing Date
2014-02-12
Accepted
2014-02-12 14:25:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G agi-protalixbiotherapeutic.htm SC 13G 94409
  Complete submission text file 0001445305-14-000397.txt   96109
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 14599366
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 212-739-3000
Allianz Global Investors U.S. Holdings LLC (Filed by) CIK: 0001567940 (see all company filings)

EIN.: 330977088 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G